Testmate Health’s Post

For a #startup, time is an invaluable resource. Inspira Technologies harnesses this principle with remarkable #laboratory capabilities that speed up #development and streamline #research. Dr. Daniella Yeheskely-Hayon, CTO of Inspira Technologies, encapsulates this ethos: "Inspira Technologies focuses on developing advanced blood monitoring and oxygen delivery technologies through its high-end testing platforms which allows it perform wider range-controlled testing while minimizing the need to perform in vivo animal testing." This innovative approach not only accelerates progress but also reiterates our commitment to boundary-pushing in medical research. Discover more >> https://lnkd.in/deuxwWbg #InspiraTechnologie #MedicalDevices #StartupNation #MedTech #HealthCare

We are happy, proud and thrilled about this project with Orgenesis Belgium and Université catholique de Louvain (TRAIL - TRusted AI Labs / Benoit Macq's team). It perfectly fits in DNAlytics roadmap for the development of world-class data-driven biomanufacturing, which revolves around these three elements : 1) Our data sciences methodology for data-driven biomanufacturing is constantly evolving, with more than 25 biomanufacturing processes scrutinized by our colleagues and/or our Hercule software platform. Some testimonials have been shared recently by Xpress Biologics, CER Groupe and another one, with GSK will be shared soon at an A3P Association congress in Lausanne on 19 March. 2) We are extending the Hercule capabilities to also deal with bioprocess development, on top of the already present features for bioprocesses improvement, through a collaboration with UCB, UMONS and CER Groupe. This project, aims at developing innovative end-to-end and multi-sources DoE capabilities. 3) This new ATMP PIT project completes the picture, to also deal with decentralized manufacturing. See details in Pierre Lammeretz post below. This project is implemented in the context of the ATMP PIT program set up by the Walloon ecosystem, with the support of BioWin - The Health Cluster of Wallonia, Service public de Wallonie, Willy Borsus and Thomas Dermine. Want to now more ? Let's talk.

💊 Come Shift the Mindset In Medicine with us at Cicada x Tech23! 💊 Join us at Cicada x Tech23 as we ask how deep tech innovations can shift the medical model from cure to prevention – from treating disease to preemptive, holistic health for everyone. Incredible opportunities exist for innovation in medicine, such as advanced diagnostic tools, robotic systems, personalised treatment technologies, and next-generation drug delivery methods. But what if we shifted our thinking to address the root cause of our problems?  From treating diseases to preventing them, from cure-alls to health for all - we might transform the healthcare system to one that truly focuses on efficiency and accessibility and one tailored to individual needs. Meet the companies featured at Cicada x Tech23 who are helping make that shift: ⭐ ShanShan Wang, CEO and Founder of Roam Technologies (roamtech.ai) is designing a portable oxygen concentrator (iPOC) called JUNO. ⭐ Sylvia C., Director and Co-Founder of OminiWell Pty Ltd,  who are developing a BioTwin Chip to deliver precise cancer treatment solutions via an in vitro cell culture device capable of cultivating patient tumour tissues outside the body. ⭐ Ali Fathi, CTO and Founder of Tetratherix, who have developed the first biostealth fluid matrix to disrupt regenerative medicine and targeted mRNA delivery. ⭐Stefan Mazy, CEO and Founder of DermR Health Solutions, is designing a world-first microneedle patch that painlessly collects skin cells and screens across the spectrum of skin cancers. ⭐ Chris Jeffery, CEO & Co-Founder of Convergence Medical, is developing the world’s first arthroscopic robot to replace outdated and unreliable arthroscopy equipment.     Don’t miss out on this opportunity to be in the room at Cicada x Tech23 🗓️  Date & Time: Wednesday, 7th August 2024 📍  Where: Doltone House, Jones Bay Wharf 🎟️  Secure your place now and be part of Australia’s premier deep tech festival.  https://lnkd.in/geeeK8ND #CxT23 #deeptech #innovation #medicine #tech #healthcare #healthstartups #techstartups #techinnovation #techfestival

Revolutionizing Healthcare with Emerging HealthTech Startups! Discover the future of patient care with innovative startups like Notable Labs, Tempus, and Butterfly Network. These trailblazers are transforming cancer treatment, precision medicine, and medical imaging. Stay ahead of the curve and explore how these companies are set to disrupt the healthcare industry in 2024. 🌐🩺 #HealthTech #Innovation #FutureOfHealthcare

Speaking of sandboxes: here's Lithuania's first (streamlined) case of a startup receiving secondary medical data, to enable better cancer treatment Q&A algorithms, currently in deployment across several EU states. Kudos, BrachyDOSE and Neringa! (Aaand we have two more finalists, that are in advanced stages of project definition and approvals - one, working on big data and prediction, and another, focused on biobank and therapeutics. Isn't that quite the traction?) This pilot is the result of six months of behind-the-scenes work by a bunch of volunteers from six cross-sectoral institutions. Major shout out to project leaders Inga Kanapeckiene and Viktorija Butrimaitė from EIT Health RIS Hub Lithuania, partly coordinated by the Lithuanian University of Health Sciences (LSMU); as well as: - LSMU Hospital Kaunas Clinics (The Hospital of Lithuanian University of Health Sciences Kauno klinikos & Antanas Montvila), - LSMU Kaunas Hospital (Lietuvos sveikatos mokslų universiteto Kauno ligoninė), - Vilnius University Santaros Clinics' Biobank (VUL Santaros klinikos & Daniel Naumovas), - the State Data Agency (Valstybės duomenų agentūra & Dr Julius Juodakis), - the Innovation Agency (Inovacijų agentūra & Jekaterina Kaliniene, EMBA), - and Ellex Legal. We at Baltic Sandbox Ventures are super proud to be part of this pilot! And major thanks to Deputy Ministers Erika Kuročkina (Ekonomikos ir inovacijų ministerija) and Olegas Niaksu (Lietuvos Respublikos sveikatos apsaugos ministerija) for their support along the way. In the longer term - we hope to turn this into a robust mechanism for more startups, more data, more patient benefits.

The Future of HealthTech is Here! Emerging startups are driving the next wave of healthcare innovation. From AI-powered diagnostics by Zebra Medical Vision to early cancer detection by GRAIL, these companies are revolutionizing patient care. Stay informed about these game-changers and their potential to reshape the health tech landscape. 🚀🩺 #HealthTechStartups #MedicalInnovation #FutureOfMedicine

😲 February is only halfway through but it's already been a busy and successful month for the AMIRES #Health & #Biotech Programme! 🎉 On 6th February 2024, we hosted the “Pioneering Digital Transformation in Healthcare” #workshop, which was a great success! The event brought together different projects in AMIRES Health & Biotech portfolio: PANCAIM, NetZeroAICT, RES-Q+, as well as longstanding partners as well as external speakers and guests. The insights and experiences shared by speakers covered #digitalhealth from a variety of perspectives. During the #networking reception, many ideas on ongoing #projects and future #cooperation opportunities were exchanged - we hope that we will see some of them come to life in the near future! A big thank you to all speakers and participants for the active engagement during the workshop! 😊 ➡ Read more about our key #takeaways from the workshop: https://lnkd.in/eG7xaKht 👋 Following the event, from the 7th to 8th February, we welcomed the PANCAIM partners in Prague for the project's M36 Meeting where we discussed exciting #progress in the development of #AI for #pancreaticcancer! More info on that here: https://lnkd.in/eass_jjY 🔬 Meanwhile, MedPhab Pilot Line partners have met in Leuven, Belgium, at imec site to plan last phase of the project and transitioning towards a MedPhab non-profit association led by VTT. Visit www.medphab.com to see how #MedPhab can help you accelerate #photonic medical device development! ✅Lastly, the beginning of the year is the season of project reviews, and our colleagues are presenting their activities and achievements in #projectmanagement and #dissemination to the European Commission! eCAP Project has successfully completed the EC review procedure in January, while the PANCAIM review meeting is upcoming on 16th of February. We keep our fingers crossed for helpful feedback and a positive evaluation of our work! #HealthcareHorizons #healthcareinnovation #biotechnews 

CytoVeris is honored to be selected as a part of the 2024 MedTech Innovator cohort – MedTech Innovator is the world’s largest accelerator of medical technology companies: This was a particularly competitive year, with around 1,400 applying for approximately 65 spots in this year's final cohort.  Explore the full list of participating companies here: https://lnkd.in/eq8zbHmR We look forward working with industry experts to further our mission to bring enhanced tissue ID and cancer margin visualization to MIS & robotic procedures. #MedTechInnovator #CytoVeris #Cancersurgery #AI #Labelfree #autofluorescence #cancermargin#multispectral #intraoperativeimaging #Advancedvisualization #Precisionsurgery #metech #cancerdetection#enhancedimaging #roboticsurgery

Thrilled to share my ongoing journey as a representative of #Checkeye, an AI-based #screening platform, diving into the #US Market Gateway Winter 2024 Accelerator Program for #BioSciences and #MedTech Leaders. It's an exhilarating opportunity to immerse ourselves in one of the world's most intricate #healthcare landscapes. The American healthcare market is indeed unique... vastly different from European one, and presents a complexity that's both challenging and rich with opportunities. This distinction underscores the necessity of gaining in-depth knowledge to navigate and innovate within this space effectively. Participating in this accelerator program is a REAL gateway to acquiring cutting-edge insights from the leading experts in American MedTech and Healthcare. It's not just about understanding the market dynamics but also about tapping into the myriad of opportunities that the US healthcare sector uniquely offers. At #Checkeye, our mission is ambitious yet straightforward - to increase the number of healthy life years by 15 worldwide, aiming to positively impact 2.5 billion people across the globe.I clearly see that insights and knowledge gained from this program will be instrumental in tailoring our strategies and solutions to fit the US healthcare system, marking a significant step towards achieving our global health goals. #HealthTech #Innovation #USHealthcare #MedTech #AcceleratorProgram #GlobalHealth #Checkeye

#vcls #clinicaldevelopment #clinicaltrials Thanks to all for this inspiring workshop